Global Peptide Synthesis Market Size, Share Forecasts to 2035

The global Peptide Synthesis market size was USD 4.3 Billion in 2021 and is projected to reach USD 6.2 Billion by 2030, exhibiting a CAGR of 7.7% during the forecast period. Peptide molecules have acquired a lot of traction in the healthcare and nutrition industries, and there have been various technological breakthroughs to help in peptide manufacture and synthesis. This pattern has been seen in both enzymatic and chemical peptide production. The usage of peptides in the pharmaceutical and consumer healthcare industries is driving the market's expansion. Peptides offer a wide range of uses in the treatment of malignancies, diabetes, and obesity, among other lifestyle problems. The rising prevalence of these metabolic and lifestyle diseases is opening the path for peptide therapies to be used in oncology and metabolic illnesses. According to a survey published by the International Diabetes Federation in 2020, around 463 million individuals have diabetes in 2019, with the prevalence expected to reach 700 million by 2045. Kind 2 diabetes is the most common type of diabetes, accounting for over 90% of all diabetes cases worldwide.